Adams announced in May 2025 that he had been diagnosed with cancer, and his ex-wife and caretaker, Shelly Miles, said he is “not with us anymore.” ...
Prince Harry and King Charles will apparently not cross paths when the Duke of Sussex visits the United Kingdom later this ...
When Nigeria's revered octogenarian industrialist, Chief Rasaq Akanni Okoya, chose compassion over celebration to mark his 86th birthday, it was a moment that blended gratitude, grace and generosity: ...
A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...
The region’s hub of diagnostics and testing firms saw a slight increase in employment for the first time in four years, ...
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact ...
Mr. Green, a 50-something businessman was asking a question I find myself answering on a surprisingly regular basis: “So, my ...
Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation ...
The International Association of Fire Fighters reports nearly 80% of their members' line-of-duty deaths were due to cancer ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback